90Y-DOTA-anti-CD25 Basiliximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 90Y-DOTA-anti-CD25 Basiliximab, covering 2025-07-08 to 2025-07-08. Get the full timeline:
Most recent: Clinical Trial Update: 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome [Phase 1]